Bionano Genomics BNGOW 深 沪
已收盘 08-17 16:00:00 美东时间
0.0036
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0036
- 总市值 100.37万
- 52周最高 0.604
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.0019
- 委 比 0.00%
- 总股本 2.79亿
- 历史最高 11.82
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.0019
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Bionano Genomics, Inc. announced that its management will present and host 1x1 meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, at 10:30 a.m. ET. Al Luderer, PhD, Chairman and Interim CEO, will present. The session will be available via webcast and replay through the Bionano website for 90 days. Bionano provides genome analysis solutions using optical genome mapping (OGM) for research and diagnostics...
08-24 12:00
Bionano Genomics Q2 Earnings Preview
Bionano Genomics (BNGO) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. The consensus EPS Estimate is -$0.67 and the consensus Revenue Estimate is $7.48M More ...
08-08 05:35
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
Bionano Genomics, Inc. (Nasdaq: BNGO) will host a conference call and live webcast on Monday, August 10, 2026, at 4:30 p.m. ET to discuss its second-quarter 2026 financial results and recent corporate progress. Participants can join via the provided registration links. A replay will be available on Bionano’s investor relations website for at least 30 days. For more information, contact Al Luderer at +1 (781) 507-4438 or Investor Relations at +1 (...
07-27 20:05
Bionano Genomics Names Alex Hastie Chief Scientific Officer
BioNano Genomics ( ($BNGO) ) just unveiled an announcement. On June 24, 2026, B...
06-24 21:01
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
Bionano Genomics reported significant growth in optical genome mapping (OGM) studies at the 2026 European Society of Human Genetics (ESHG) conference, with a 67% increase in studies compared to 2025. The research spanned 17 countries across five global markets, focusing on rare genetic disorders, hematologic malignancies, reproductive health, and cardiovascular genomics. Brazil was the top national contributor, while Europe led overall. OGM was u...
06-18 12:00
BioNano Genomics Announces Resignation of Chief Medical Officer
BioNano Genomics ( ($BNGO) ) has shared an announcement. On June 2, 2026, Biona...
06-06 05:21
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call
Bionano Genomics (NASDAQ:BNGO) reported first-quarter financial results on Wedn...
05-14 05:10
Bionano Genomics Q1 EPS $(0.76) Beats $(0.95) Estimate, Sales $6.687M Beat $6.567M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.95) by 20 percent. This is a 33.91 percent increase over losses of $(1.15) per share from the
05-14 04:11
Bionano Genomics Sees Q2 Sales $7.500M-$7.800M vs $7.520M Est
Bionano Genomics (NASDAQ:BNGO) sees Q2 sales of $7.500 million-$7.800 million vs $7.520 million analyst estimate.
05-14 04:08
Bionano Genomics Affirms FY2026 Sales Guidance of $30.000M-$33.000M vs $32.137M Est
Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $30.000 million-$33.000 million to $30.000 million-$33.000 million vs $32.137 million estimate.
05-14 04:07
